secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001140361-25-018543
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis Q1 2025 revenue $1.9M (+3% YoY); net loss narrows to $3.0M
-------------------------------------------------------------------

- Revenue $1.9M (+3% YoY); consumables utilization +4%; pediatric revenue +38%.
- Operating expenses down 31% to $4.1M; operating loss improved to $3.1M from $4.7M.
- Net loss $3.0M ($0.69/sh) vs $3.8M ($24.11/sh) in Q1 2024.
- CMS reassigned Aquadex to higher outpatient reimbursement (4x to $1,639/day) effective Jan 1, 2025.
- Cash $2.6M, debt-free.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036125018543/0001140361-25-018543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036125018543/ef20048675_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-018543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer